Liberty Star Uranium & Metals (LBSR) 10-Q 20 Dec 21 2022 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Oct. 31, 2021	Dec. 20, 2021
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Oct. 31, 2021
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--01-31
Entity File Number	000-50071
Entity Registrant Name	LIBERTY STAR URANIUM & METALS CORP.
Entity Central Index Key	0001172178
Entity Tax Identification Number	90-0175540
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	2 East Congress Street Ste. 900
Entity Address, City or Town	Tucson
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85701
City Area Code	520
Local Phone Number	425-1433
Title of 12(b) Security	Common
Trading Symbol	LBSR
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		11,055,882

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Oct. 31, 2021	Jan. 31, 2021
Current:
Cash and cash equivalents	$ 25,144	$ 6,718
Prepaid expenses	14,740	4,815
Total current assets	39,884	11,533
Property and equipment, net	29,181	33,556
Total assets	69,065	45,089
Liabilities and Stockholders’ Deficit
Accounts payable and accrued liabilities	495,071	467,957
Accounts payable to related parties	51,119	51,119
Accrued wages to related parties	811,711	811,711
Advances from related party	328,220	301,077
Notes payable to related parties	310,828	283,271
Convertible promissory note, net of unamortized debt discount of $31,006 and $7,642	134,249	87,969
Derivative liability	323,220
Total current liabilities	2,454,418	2,003,104
Long-term:
Long-term accounts payable, net of current portion		20,300
Long-term debt - SBA	66,796	33,162
Total long-term liabilities	66,796	53,462
Total liabilities	2,521,214	2,056,566
Commitments and Contingencies (Note 10)
Stockholders’ deficit:
Common stock value	108	99
Common stock to be issued		15,000
Stock subscription receivable	(132,374)
Additional paid-in capital	55,537,526	55,503,564
Accumulated deficit	(57,857,410)	(57,530,141)
Total stockholders’ deficit	(2,452,149)	(2,011,477)
Total liabilities and stockholders’ deficit	69,065	45,089
Common Class A [Member]
Stockholders’ deficit:
Common stock value	$ 1	$ 1

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)	Oct. 31, 2021	Jan. 31, 2021
Convertible promissory note, debt discount	$ 31,006	$ 7,642
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	24,800,000	24,800,000
Common stock, shares issued	10,785,202	9,902,052
Common stock, shares outstanding	10,785,202	9,902,052
Common Class A [Member]
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	200,000	0
Common stock, shares issued	102,000
Common stock, shares outstanding	102,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020	Oct. 31, 2021	Oct. 31, 2020
Income Statement [Abstract]
Revenues
Expenses:
Geological and geophysical costs	51,928	48,784	58,489	103,335
Salaries and benefits	26,514	36,871	100,270	108,592
Public relations	11,123		15,656
Depreciation	1,458	1,531	4,375	4,878
Legal	26,253	49,990	52,704	145,462
Professional services	30,788	17,567	74,870	61,000
General and administrative	24,743	17,424	63,037	51,089
Travel	4,539	6,354	5,179	6,793
Net operating expenses	177,346	178,521	374,580	481,149
Loss from operations	(177,346)	(178,521)	(374,580)	(481,149)
Other income (expense):
Interest expense	(24,933)	(6,941)	(119,306)	(173,643)
Gain (loss) on change in fair value of derivative liability	89,627		166,617	(39,631)
Total other income (expense)	64,694	(6,941)	47,311	(213,274)
Net loss	$ (112,652)	$ (185,462)	$ (327,269)	$ (694,423)
Net loss per share of common stock - basic and diluted	$ (0.01)	$ (0.02)	$ (0.03)	$ (0.07)
Weighted average number of shares of common stock outstanding - basic and diluted	10,525,072	10,001,644	10,272,721	9,660,741

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)	Common Stock [Member]Common Class A [Member]	Common Stock [Member]	Common Stock To Be Issued Member	Stock Subscription Receivable Member	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Jan. 31, 2020		$ 91			$ 55,074,257	$ (56,780,396)	$ (1,706,048)
Beginning Balance, shares at Jan. 31, 2020		9,116,725
Issuance of common stock and warrants in private placement		$ 1			20,598		20,599
Issuance of common stock and warrants in private placement, shares		54,000
Shares issued for conversion of notes		$ 4			106,796		106,800
Shares issued for conversion of notes, shares		390,481
Reclass of APIC to derivative liabilities for tainted warrants					(189,472)		(189,472)
Resolution of derivative liabilities due to debt conversions					106,514		106,514
Net loss						(183,741)	(183,741)
Ending balance, value at Apr. 30, 2020		$ 96			55,118,693	(56,964,137)	(1,845,348)
Ending Balance, shares at Apr. 30, 2020		9,561,206
Beginning balance, value at Jan. 31, 2020		$ 91			55,074,257	(56,780,396)	(1,706,048)
Beginning Balance, shares at Jan. 31, 2020		9,116,725
Net loss							(694,423)
Ending balance, value at Oct. 31, 2020	$ 1	$ 99			55,543,400	(57,474,819)	(1,931,319)
Ending Balance, shares at Oct. 31, 2020	102,000	9,899,644
Beginning balance, value at Apr. 30, 2020		$ 96			55,118,693	(56,964,137)	(1,845,348)
Beginning Balance, shares at Apr. 30, 2020		9,561,206
Class A Shares issued to settle related party advances and notes payable	$ 1				49,061		49,062
Class A Shares issued to settle related party advances and notes payable, shares	102,000
Shares issued for conversion of notes		$ 2			63,058		63,060
Shares issued for conversion of notes, shares		195,581
Shares issued for services		$ 1			49,999		50,000
Shares issued for services, shares		142,857
Resolution of derivative liabilities due to debt conversions					262,589		262,589
Net loss						(325,220)	(325,220)
Ending balance, value at Jul. 31, 2020	$ 1	$ 99			55,543,400	(57,289,357)	(1,745,857)
Ending Balance, shares at Jul. 31, 2020	102,000	9,899,644
Net loss						(185,462)	(185,462)
Ending balance, value at Oct. 31, 2020	$ 1	$ 99			55,543,400	(57,474,819)	(1,931,319)
Ending Balance, shares at Oct. 31, 2020	102,000	9,899,644
Beginning balance, value at Jan. 31, 2021	$ 1	$ 99	15,000		55,503,564	(57,530,141)	(2,011,477)
Beginning Balance, shares at Jan. 31, 2021	102,000	9,902,052
Issuance of common stock and warrants in private placement		$ 1	(15,000)		122,099		107,100
Issuance of common stock and warrants in private placement, shares		116,230
Shares issued for conversion of notes		$ 1			26,999		27,000
Shares issued for conversion of notes, shares		33,881
Reclass of APIC to derivative liabilities for tainted warrants					(293,528)		(293,528)
Resolution of derivative liabilities due to debt conversions					17,406		17,406
Net loss						(81,624)	(81,624)
Ending balance, value at Apr. 30, 2021	$ 1	$ 101			55,376,540	(57,611,765)	(2,235,123)
Ending Balance, shares at Apr. 30, 2021	102,000	10,052,163
Beginning balance, value at Jan. 31, 2021	$ 1	$ 99	15,000		55,503,564	(57,530,141)	(2,011,477)
Beginning Balance, shares at Jan. 31, 2021	102,000	9,902,052
Net loss							(327,269)
Ending balance, value at Oct. 31, 2021	$ 1	$ 108		(132,374)	55,537,526	(57,857,410)	(2,452,149)
Ending Balance, shares at Oct. 31, 2021	102,000	10,785,202
Beginning balance, value at Apr. 30, 2021	$ 1	$ 101			55,376,540	(57,611,765)	(2,235,123)
Beginning Balance, shares at Apr. 30, 2021	102,000	10,052,163
Shares issued for conversion of notes		$ 1			69,899		69,900
Shares issued for conversion of notes, shares		98,472
Resolution of derivative liabilities due to debt conversions					263,956		263,956
Net loss						(132,993)	(132,993)
Ending balance, value at Jul. 31, 2021	$ 1	$ 102			55,710,395	(57,744,758)	(2,034,260)
Ending Balance, shares at Jul. 31, 2021	102,000	10,150,635
Issuance of common stock and warrants in private placement		$ 1			49,999		50,000
Issuance of common stock and warrants in private placement, shares		86,873
Issuance of common stock for cash pursuant to investment agreement		$ 5		(132,374)	132,369
Issuance of common stock for cash pursuant to investment agreement, shares		490,196
Shares issued for conversion of notes					25,000		25,000
Shares issued for conversion of notes, shares		57,498
Reclass of APIC to derivative liabilities for tainted warrants					(392,617)		(392,617)
Resolution of derivative liabilities due to debt conversions					12,380		12,380
Net loss						(112,652)	(112,652)
Ending balance, value at Oct. 31, 2021	$ 1	$ 108		$ (132,374)	$ 55,537,526	$ (57,857,410)	$ (2,452,149)
Ending Balance, shares at Oct. 31, 2021	102,000	10,785,202

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Cash flows from operating activities:
Net loss	$ (327,269)	$ (694,423)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	4,375	4,878
Amortization of debt discounts	89,370	155,776
Expenses paid by related parties	35,854
Gain (loss) on change in fair value of derivative liabilities	(166,617)	39,631
Common shares issued for third party services		50,000
Changes in assets and liabilities:
Prepaid expenses	(9,925)	(7,091)
Accounts payable and accrued expenses	6,815	144,959
Accrued interest	26,226	17,681
Cash flows used in operating activities:	(341,171)	(288,589)
Cash flows from financing activities:
Proceeds from notes payable	32,497	62,974
Cash advance from related party		52,000
Proceeds from notes payable, related parties		120,000
Proceeds from convertible promissory notes	170,000	82,000
Proceeds from the issuance of common stock and warrants	155,000	20,599
Proceeds from exercise of warrants	2,100
Net cash provided by financing activities	359,597	337,573
Increase in cash and cash equivalents	18,426	48,984
Cash and cash equivalents, beginning of period	6,718	25,024
Cash and cash equivalents, end of period	25,144	74,008
Supplemental disclosure of cash flow information:
Income tax paid
Interest paid
Supplemental disclosure of non-cash items:
Resolution of derivative liabilities due to debt conversions and untainted warrants	293,742	369,103
Reclass of APIC to derivative liabilities for tainted warrants	686,145	189,472
Debt discounts due to derivative liabilities	97,434	140,000
Common stock issued for conversion of debt and interest	121,900	169,860
Class A Common Stock issued for conversion of related party advances and notes payable		49,062
Expenses paid by related party on behalf of the Company	$ 35,854	$ 148,698

Basis of Presentation

Basis of Presentation	9 Months Ended
	Oct. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation	NOTE 1 – Basis of Presentation The condensed consolidated financial statements included herein have been prepared by Liberty Star Uranium & Metals Corp. (the “Company”, “we”, “our”) without audit, pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”) and should be read in conjunction with our annual report on Form 10-K for the year ended January 31, 2021 as filed with the SEC under the Securities and Exchange Act of 1934 (the “Exchange Act”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted, as permitted by the SEC, although we believe the disclosures which are made are adequate to make the information presented not misleading. The condensed consolidated financial statements reflect, in the opinion of management, all normal recurring adjustments necessary to present fairly our financial position at October 31, 2021 and the results of our operations and cash flows for the periods presented. Interim results are subject to significant seasonal variations and the results of operations for the three and nine months ended October 31,2021 are not necessarily indicative of the results to be expected for the full year. Reverse Stock Split On November 24, 2020, the Company filed a Certificate of Change with the Secretary of the State of Nevada to affect a 1-for-500 reverse stock split (the “Reverse Stock Split”). The Reverse Stock Split was formally processed by FINRA effective on February 25, 2021, and the Company’s common stock began trading on a split-adjusted basis on February 25, 2021. Prior to the effective date of the Certificate of Change, the Company was authorized to issue 6,150,000,000 12,300,000 Prior to the effective date of the Certificate of Change, the Company was authorized to issue 100,000,000 200,000 51,000,000 All references to common shares and common share data in these condensed consolidated financial statements and elsewhere in this Form 10-Q reflect the Reverse Stock Split.

Going concern

Going concern	9 Months Ended
	Oct. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going concern	NOTE 2 – Going concern The Company has incurred losses from operations and requires additional funds for further exploratory activity and to maintain its claims prior to attaining a revenue generating status. There are no assurances that a commercially viable mineral deposit exists on any of our properties. In addition, the Company may not find sufficient ore reserves to be commercially mined. As such, there is substantial doubt about the Company’s ability to continue as a going concern. Management is working to secure additional funds through the exercise of stock warrants already outstanding, equity financings, debt financings or joint venture agreements. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Oct. 31, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 3 – Summary of Significant Accounting Policies Fair Value ASC 820 Fair Value Measurements and Disclosures (“ASC 820”), defines fair value, establishes a framework for measuring fair value and enhances disclosures about fair value measurements. It defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities that are not active; and model-driven valuations whose inputs are observable or whose significant value drivers are observable. Valuations may be obtained from, or corroborated by, third-party pricing services. Level 3: Unobservable inputs to measure fair value of assets and liabilities for which there is little, if any market activity at the measurement date, using reasonable inputs and assumptions based upon the best information at the time, to the extent that inputs are available without undue cost and effort. Schedule of Fair Value of Financial Instruments Fair value measurements at reporting date using: Description Fair Value Quoted prices in Significant other observable inputs (Level 2) Significant unobservable (Level 3) Warrant and convertible note derivative liability at October 31, 2021 $ - - - $ - Warrant and convertible note derivative liability at January 31, 2021 $ - - - $ - Our financial instruments consist of cash and cash equivalents, prepaid expenses, accounts payable, accrued liabilities, notes payable, convertible notes payable, and derivative liability. It is management’s opinion that we are not exposed to significant interest, currency or credit risks arising from these financial instruments. With the exception of the derivative liability, the fair value of these financial instruments approximates their carrying values based on their short maturities or for long-term debt based on borrowing rates currently available to us for loans with similar terms and maturities. Gains and losses recognized on changes in estimated fair value of the derivative liability are reported in other income (expense) as gain (loss) on change in fair value of derivative liability.

Related party transactions

Related party transactions	9 Months Ended
	Oct. 31, 2021
Related Party Transactions [Abstract]
Related party transactions	NOTE 4 – Related party transactions Our CEO, Brett Gross, was elected as President and Chief Executive Officer on December 7, 2018, and received no compensation for these services during the three and nine months ended October 31,2021 and 2020. Advances From October 2019 through October 31, 2021, our CEO, Brett Gross, made various payments on behalf of the Company totaling $ 175,455 62,000 328,220 301,077 Notes Payable During the nine months ended October 31, 2021, the notes payable to related parties principal increased $ 5,000 297,707 July 31, 2021 The Company has a note payable of $ 10,000 September 17, 2019 10% As of October 31, and January 31, 2021, the total balance of all related party notes payable above was $ 310,828 283,271 54,915 36,070 Accrued Wages As of October 31, and January 31, 2021, we had a balance of accrued unpaid wages of $ 759,949 15,625 36,137 Accounts Payable As of October 31, and January 31, 2021, we had an aggregate balance due of approximately $ 167,000 As of October 31, and January 31, 2021, we had accounts payable to JABA (controlled by James Briscoe) of $ 34,798 As of October 31, and January 31, 2021, we had a balance of $ 16,321

Stock options

Stock options	9 Months Ended
	Oct. 31, 2021
Share-based Payment Arrangement [Abstract]
Stock options	NOTE 5 – Stock options Qualified and Non-qualified incentive stock options outstanding at October 31, 2021 are as follows: Schedule of Stock Options Activity Weighted Number of exercise options price per share Outstanding, January 31, 2021 146,000 $ 3.019 Granted - - Expired - - Exercised - - Outstanding, October 31, 2021 146,000 $ 3.019 Exercisable, October 31, 2021 146,000 $ 3.019 These options had a weighted average remaining life of 6.87 0 During the nine months ended October 31, 2021 and 2020, we recognized $ 0 0

Warrants

Warrants	9 Months Ended
	Oct. 31, 2021
Warrants
Warrants	NOTE 6 – Warrants As of October 31, 2021, there were 1,000,250 3.34 1.979 5,220 Stock warrants outstanding at October 31, 2021 are as follows: Schedule of Stock Warrants Outstanding Weighted average Number of warrants exercise Outstanding, January 31, 2021 400,166 $ 2.155 Issued 606,084 1.846 Expired - - Exercised (6,000 ) 0.350 Outstanding, October 31, 2021 1,000,250 $ 1.979 Exercisable, October 31, 2021 1,000,250 $ 1.979 During the nine months ended October 31, 2021, the Company issued 98,552 three-year term 0.805 1.646 507,532 five-year warrants 1,000,000 As of June 17, 2021, the Company extended all warrants issued by the Company which expired or will expire during the year 2021. These warrants are extended for an additional three years. All other terms of the warrants remain unchanged, including application of the reverse split effective on February 25, 2021.

Derivative Liabilities

Derivative Liabilities	9 Months Ended
	Oct. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liabilities	NOTE 7 – Derivative Liabilities The embedded conversion feature in the convertible debt instruments that the Company issued (See Note 8), that became convertible during the nine months ended October 31, 2021, qualified it as a derivative instrument since the number of shares issuable under the note is indeterminate based on guidance in FASB ASC 815, Derivatives and Hedging. These convertible notes tainted all other equity linked instruments including outstanding warrants and fixed rate convertible debt on the date that the instrument became convertible. The valuation of the derivative liability of the warrants was determined through the use of a Monte Carlo options model that values the liability of the warrants based on a risk-neutral valuation where the price of the option is its discounted expected value. The technique applied generates a large number of possible (but random) price paths for the underlying common stock via simulation, and then calculates the associated exercise value (i.e. “payoff”) of the option for each path. These payoffs are then averaged and discounted to a current valuation date resulting in the fair value of the option. The valuation of the derivative liability attached to the convertible debt was arrived at through the use of a Monte Carlo model that values the derivative liability within the notes. The technique applied generates a large number of possible (but random) price paths for the underlying (or underlyings) via simulation, and then calculates the associated payment value (cash, stock, or warrants) of the derivative features. The price of the underlying common stock is modeled such that it follows a geometric Brownian motion with constant drift, and elastic volatility (increasing as stock price decreases). The stock price is determined by a random sampling from a normal distribution. Since the underlying random process is the same, for enough price paths, the value of the derivative is derived from path dependent scenarios and outcomes. The features in the notes that were analyzed and incorporated into the model included the conversion features with the reset provisions, the call/redemption/prepayment options, and the default provisions. Based on these features, there are six primary events that can occur; payments are made in cash; payments are made with stock; the note holder converts upon receiving a redemption notice; the note holder converts the note; the issuer redeems the note; or the Company defaults on the note. The model simulates the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. stock price, conversion price, etc.). Probabilities were assigned to each variable such as redemption likelihood, default likelihood, and timing and pricing of reset events over the remaining term of the notes based on management projections. This led to a cash flow simulation over the life of the note. A discounted cash flow for each simulation was completed, and it was compared to the discounted cash flow of the note without the embedded features, thus determining a value for the derivative liability. Key inputs and assumptions used to value the convertible note when it became convertible and upon settlement, and warrants upon tainting, were as follows: ● The stock projections are based on the historical volatilities for each date. These volatilities were in the 75.4% 187.4% ● An event of default would not occur during the remaining term of the note; ● Conversion of the notes to stock would be completed monthly after any holding period and would be limited based on: 5% of the last 6 months average trading volume and the ownership limit identified in the contract assuming the underlying number of common shares increases at 1% per month. ● The effective discount was determined based on the historical trading history of the Company based on the specific pricing mechanism in each note; ● The Company would not have funds available to redeem the notes during the remaining term of the convertible notes; ● Discount rates were based on risk free rates in effect based on the remaining term and date of each valuation and instrument. ● The Holder would exercise the warrant at maturity if the stock price was above the exercise price; ● The Holder would exercise the warrant after any holding period prior to maturity at target prices starting at 2 times the exercise price for the Warrants or higher subject to monthly limits of: 5% of the last 6 months average trading volume increasing by 1% per month and the ownership limit identified in the contract assuming the underlying number of common shares increases at 1% per month. Using the results from the model, the Company recorded a derivative liability during the nine months ended October 31,2021 of $ 686,145 97,434 0 97,434 78,165 19,269 During the nine months ended October 31,2021, the Company recorded a reclassification from derivative liability to equity of $ 0 293,742 166,617 During the nine months ended October 31, 2020, the Company recorded a reclassification from derivative liability to equity of $ 189,472 369,103 39,631 The following table sets forth a reconciliation of changes in the fair value of the Company’s derivative liability: Schedule of Changes in Fair Value of Derivative Liabilities Nine months ended October 31, 2021 2020 Beginning balance $ - $ - Total (gain) loss (166,617 ) 39,631 Settlements (293,742 ) (369,103 ) Additions recognized as debt discount 97,434 140,000 Additions due to tainted warrants 686,145 189,472 Ending balance $ 323,220 $ - Change in unrealized (gain) loss included in earnings relating to derivatives $ (166,617 ) $ 39,631

Long-term debt and convertible

Long-term debt and convertible promissory notes	9 Months Ended
	Oct. 31, 2021
Debt Disclosure [Abstract]
Long-term debt and convertible promissory notes	NOTE 8 – Long-term debt and convertible promissory notes Following is a summary of convertible promissory notes: Summary of Convertible Promissory Notes October 31, 2021 January 31, 2021 8% October 2020 September 2021 $ - $ 95,611 8% April 2021 April 2022 40,596 - 8% May 2021 May 2022 55,010 - 8% October 2021 October 2022 69,649 - Convertible note payable 165,255 95,611 Less debt discount (31,006 ) (7,642 ) Less current portion of convertible notes (134,249 ) (87,969 ) Long-term convertible notes payable $ - $ - On October 28, 2020, we received net proceeds of $ 82,000 8% 8,500 3,000 September 1, 2021 180 75% 10 96,900 132,353 0 On April 26, 2021, we received net proceeds of $ 60,000 8% 3,000 April 23, 2022 180 75% 10 25,000 57,498 40,596 On May 11, 2021, we issued a convertible note in the aggregate principal amount of $ 53,000 8% 3,000 May 11, 2022 180 75% 10 On October 8, 2021, we issued a convertible promissory note in the aggregate principal amount of $ 69,300 8% October 8, 2022 180 75% 10 During the nine months ended October 31, 2021 and 2020, the Company recorded debt discounts of $ 64,823 140,000 15,300 0 76,028 155,364 Notes Payable On June 22, 2020, the Company received loan proceeds of $ 32,300 100 June 16, 2020 3.75% 30 158 June 18, 2021 June 18, 2023 On February 16, 2021, the Company received loan proceeds of $ 32,497 under the Payroll Protection Program (“PPP”). The PPP loan bears interest at 1% , has a 5 -year term, and is due in equal monthly installments beginning July 19, 2022. The company is seeking full forgiveness of this loan. The balance of these two notes total $ 66,796 1,899 In August 2021, the Company received an aggregate of $ 13,000

Stockholders_ deficit

Stockholders’ deficit	9 Months Ended
	Oct. 31, 2021
Equity [Abstract]
Stockholders’ deficit	NOTE 9 – Stockholders’ deficit Common Stock Our undesignated common shares are all of the same class, are voting and entitle stockholders to receive dividends as defined. Upon liquidation or wind-up, stockholders are entitled to participate equally with respect to any distribution of net assets or any dividends that may be declared. On March 5, 2021, the Company issued 6,000 2,100 0.35 On March 26, 2021, the Company issued 17,006 8,503 20,000 1.176 three 1.646 In March 2021, the Company issued 49,412 24,706 55,000 1.113 three 1.558 On April 2, 2021, the Company issued 9,818 4,909 10,000 1.019 three 1.426 On April 23, 2021, the Company issued 15,049 12,000 0.797 On April 27, 2021, the Company issued 18,832 15,000 0.797 On April 30, 2021, the Company received proceeds of $ 20,000 19,268 9,634 1.038 three 1.453 In May 2021, the Company issued a total of 98,472 69,900 0.699 0.743 In October 2021, the Company issued a total of 57,498 25,000 0.435 In October 2021, the Company issued 60,887 30,444 35,000 0.575 three 0.805 In October 2021, the Company issued 25,986 12,993 15,000 0.577 three 0.808 Reverse Stock Split On November 24, 2020, the Company filed a Certificate of Change with the Secretary of the State of Nevada to affect a 1-for-500 reverse stock split (the “Reverse Stock Split”) Prior to the effective date of the Certificate of Change, the Company was authorized to issue 6,150,000,000 12,300,000 Prior to the effective date of the Certificate of Change, the Company was authorized to issue 100,000,000 200,000 102,000 2,408 All references to common shares and common share data in these unaudited condensed consolidated financial statements and elsewhere in this Form 10-Q as of October 31, 2021, and for the three and nine months ended October 31, 2021, and 2020, reflect the Reverse Stock Split. OTCQB Venture Market On August 6, 2021, the Company announced the OTC Markets Group Inc. approved the Company to trade as LBSR on the OTCQB Venture Market, designed for developing and entrepreneurial companies in the U.S. and abroad. Trading on the OTCQB began August 06, 2021. Authorized Shares Amendment On August 10, 2021, the Company’s Board of Directors (the “Board”) unanimously approved, and recommended for shareholder approval, the Amendment in order to increase the number of authorized shares of the Company’s common stock. The record date established by the Board for purposes of determining the number of outstanding shares of voting stock entitled to vote on the Amendment was August 11, 2021 (the “Record Date”). Pursuant to NRS 78.390, amendments to the Company’s Articles of Incorporation must be approved by a majority of the Company’s stockholders. In order to obtain stockholder approval for the Amendment, we could have convened a special meeting of the stockholders for the specific purpose of voting on such matter. However, NRS 78.320(2) provides than any action required or permitted to be taken at a meeting of the stockholders may be taken without a meeting if, before or after the action, a written consent thereto is signed by stockholders holding at least a majority of the voting power. In order to eliminate the costs and management time involved in holding a meeting and obtaining proxies and in order to effect the Amendment as early as possible in order to accomplish the purposes of the Amendment, the Board elected to utilize the written consent option of the holders of a majority of the outstanding shares of our common stock, as provided by Nevada law. The Company has two classes of stock authorized, Class A Stock and Common Stock. As of the Record Date, the Company had 10,150,635 102,000 Each share of Common Stock is entitled to 1 vote each share of Class A Stock is entitled to 200 votes 66.77 Pursuant to the rules and regulations promulgated by the SEC under the Exchange Act, an Information Statement must be sent to the holders of voting stock who did not sign the Written Consent at least 20 days prior to the effective date of any corporate action taken or authorized pursuant to the consent of the Company’s stockholders. These Information Statements were sent by the Company on September 10, 2021. On October 01, 2021, the registrant amended its articles of incorporation for the purposes of increasing the authorized shares of the registrant from 12,500,000 25,000,000 24,800,000 0.00001 200,000 0.00001 Purchase Agreement with Triton Funds LP On August 20, 2021, the Company executed a $ 1,000,000 1,000,000 1,000,000 It may require Triton to purchase not less than $ 25,000 250,000 5 1,000,000 20,000,000 The Registration Statement was declared effective by the Securities and Exchange Commission on September 13, 2021. On September 14, 2021, the Company issued a total of 490,196 132,374 0.27 0.51

Commitments and contingencies

Commitments and contingencies	9 Months Ended
	Oct. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingencies	NOTE 10 – Commitments and contingencies Legal Matter On August 22, 2019 (and amended on December 23, 2019), the Company filed a complaint with the Superior Court of Arizona (Case No. C20194139), demanding the titles and possession of certain vehicles and equipment of the Company from our former CEO, as well as seeking recovery of damages from the former CEO in an amount of not less than $ 50,000 On February 18, 2020, our former CEO and his spouse (the “Counterclaimants”) filed a First Amended Answer: First Amended Complaint and Counterclaim with the Superior Court of Arizona seeking dismissal of the Company’s complaint and reimbursement of Counterclaimants’ attorney fees incurred related to the matter. Additionally, the counterclaim alleges breach of contract by the Company and requests reimbursement of amounts loaned to the Company by our former CEO and his spouse, along with reimbursement of attorney fees. The Company believes these counterclaims are without merit and is aggressively defending them and believes no unfavorable outcome or material effect on our condensed consolidated financial statements will result.

Subsequent events

Subsequent events	9 Months Ended
	Oct. 31, 2021
Subsequent Events [Abstract]
Subsequent events	NOTE 11 – Subsequent events On November 15, 2021, the Company entered into a convertible promissory note (the “Note”) with Sixth Street Lending LLC. (“Sixth Street”) in the aggregate principal amount of $ 60,500 8 10 November 15, 2022 180 75 10 In November 2021, a noteholder converted a total of $ 40,520 103,692 0.39 In November and December 2021, a noteholder converted a total of $ 40,000 166,988 0.24

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 31, 2021
Accounting Policies [Abstract]
Fair Value	Fair Value ASC 820 Fair Value Measurements and Disclosures (“ASC 820”), defines fair value, establishes a framework for measuring fair value and enhances disclosures about fair value measurements. It defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities that are not active; and model-driven valuations whose inputs are observable or whose significant value drivers are observable. Valuations may be obtained from, or corroborated by, third-party pricing services. Level 3: Unobservable inputs to measure fair value of assets and liabilities for which there is little, if any market activity at the measurement date, using reasonable inputs and assumptions based upon the best information at the time, to the extent that inputs are available without undue cost and effort. Schedule of Fair Value of Financial Instruments Fair value measurements at reporting date using: Description Fair Value Quoted prices in Significant other observable inputs (Level 2) Significant unobservable (Level 3) Warrant and convertible note derivative liability at October 31, 2021 $ - - - $ - Warrant and convertible note derivative liability at January 31, 2021 $ - - - $ - Our financial instruments consist of cash and cash equivalents, prepaid expenses, accounts payable, accrued liabilities, notes payable, convertible notes payable, and derivative liability. It is management’s opinion that we are not exposed to significant interest, currency or credit risks arising from these financial instruments. With the exception of the derivative liability, the fair value of these financial instruments approximates their carrying values based on their short maturities or for long-term debt based on borrowing rates currently available to us for loans with similar terms and maturities. Gains and losses recognized on changes in estimated fair value of the derivative liability are reported in other income (expense) as gain (loss) on change in fair value of derivative liability.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Oct. 31, 2021
Accounting Policies [Abstract]
Schedule of Fair Value of Financial Instruments	Schedule of Fair Value of Financial Instruments Fair value measurements at reporting date using: Description Fair Value Quoted prices in Significant other observable inputs (Level 2) Significant unobservable (Level 3) Warrant and convertible note derivative liability at October 31, 2021 $ - - - $ - Warrant and convertible note derivative liability at January 31, 2021 $ - - - $ -

Stock options (Tables)

Stock options (Tables)	9 Months Ended
	Oct. 31, 2021
Share-based Payment Arrangement [Abstract]
Schedule of Stock Options Activity	Qualified and Non-qualified incentive stock options outstanding at October 31, 2021 are as follows: Schedule of Stock Options Activity Weighted Number of exercise options price per share Outstanding, January 31, 2021 146,000 $ 3.019 Granted - - Expired - - Exercised - - Outstanding, October 31, 2021 146,000 $ 3.019 Exercisable, October 31, 2021 146,000 $ 3.019

Warrants (Tables)

Warrants (Tables)	9 Months Ended
	Oct. 31, 2021
Warrants
Schedule of Stock Warrants Outstanding	Stock warrants outstanding at October 31, 2021 are as follows: Schedule of Stock Warrants Outstanding Weighted average Number of warrants exercise Outstanding, January 31, 2021 400,166 $ 2.155 Issued 606,084 1.846 Expired - - Exercised (6,000 ) 0.350 Outstanding, October 31, 2021 1,000,250 $ 1.979 Exercisable, October 31, 2021 1,000,250 $ 1.979

Derivative Liabilities (Tables)

Derivative Liabilities (Tables)	9 Months Ended
	Oct. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Changes in Fair Value of Derivative Liabilities	The following table sets forth a reconciliation of changes in the fair value of the Company’s derivative liability: Schedule of Changes in Fair Value of Derivative Liabilities Nine months ended October 31, 2021 2020 Beginning balance $ - $ - Total (gain) loss (166,617 ) 39,631 Settlements (293,742 ) (369,103 ) Additions recognized as debt discount 97,434 140,000 Additions due to tainted warrants 686,145 189,472 Ending balance $ 323,220 $ - Change in unrealized (gain) loss included in earnings relating to derivatives $ (166,617 ) $ 39,631

Long-term debt and convertibl_2

Long-term debt and convertible promissory notes (Tables)	9 Months Ended
	Oct. 31, 2021
Debt Disclosure [Abstract]
Summary of Convertible Promissory Notes	Following is a summary of convertible promissory notes: Summary of Convertible Promissory Notes October 31, 2021 January 31, 2021 8% October 2020 September 2021 $ - $ 95,611 8% April 2021 April 2022 40,596 - 8% May 2021 May 2022 55,010 - 8% October 2021 October 2022 69,649 - Convertible note payable 165,255 95,611 Less debt discount (31,006 ) (7,642 ) Less current portion of convertible notes (134,249 ) (87,969 ) Long-term convertible notes payable $ - $ -

Schedule of Fair Value of Finan

Schedule of Fair Value of Financial Instruments (Details) - USD ($)	Oct. 31, 2021	Jan. 31, 2021
Defined Benefit Plan Disclosure [Line Items]
Warrant and convertible note derivative liability
Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Warrant and convertible note derivative liability
Fair Value, Inputs, Level 2 [Member]
Defined Benefit Plan Disclosure [Line Items]
Warrant and convertible note derivative liability
Fair Value, Inputs, Level 3 [Member]
Defined Benefit Plan Disclosure [Line Items]
Warrant and convertible note derivative liability

Basis of Presentation (Details

Basis of Presentation (Details Narrative) - shares	Nov. 24, 2020	Oct. 31, 2021	Oct. 02, 2021	Sep. 30, 2021	Feb. 24, 2021	Jan. 31, 2021	Nov. 23, 2020
Stockholders' Equity, Reverse Stock Split	On November 24, 2020, the Company filed a Certificate of Change with the Secretary of the State of Nevada to affect a 1-for-500 reverse stock split (the “Reverse Stock Split”)	On November 24, 2020, the Company filed a Certificate of Change with the Secretary of the State of Nevada to affect a 1-for-500 reverse stock split (the “Reverse Stock Split”). The Reverse Stock Split was formally processed by FINRA effective on February 25, 2021, and the Company’s common stock began trading on a split-adjusted basis on February 25, 2021.
Common stock, shares authorized	12,300,000	24,800,000	25,000,000	12,500,000		24,800,000	6,150,000,000
Common stock, shares outstanding		10,785,202				9,902,052
Common Class A [Member]
Common stock, shares authorized	200,000	200,000				0	100,000,000
Common stock, shares outstanding	102,000	102,000			51,000,000

Related party transactions (Det

Related party transactions (Details Narrative) - USD ($)	Oct. 31, 2021	Sep. 17, 2018	Oct. 31, 2021	Jan. 31, 2021
Related Party Transaction [Line Items]
Due to Officers or Stockholders, Current	$ 328,220		$ 328,220	$ 301,077
Notes payable to related party	310,828		310,828	283,271
Interest Payable	54,915		54,915	36,070
Employee-related liabilities, current	811,711		811,711	811,711
James Briscoe [Member]
Related Party Transaction [Line Items]
Debt instrument, maturity date		Sep. 17, 2019
Notes payable to related party		$ 10,000
Debt instrument, interest rate		10.00%
Employee-related liabilities, current	759,949		759,949	759,949
James Briscoe [Member] | Accounts Payable and Accrued Liabilities [Member]
Related Party Transaction [Line Items]
Due to related party	167,000		167,000	167,000
James Briscoe [Member] | Accounts Payable [Member]
Related Party Transaction [Line Items]
Due to related party	34,798		34,798	34,798
Former President [Member]
Related Party Transaction [Line Items]
Employee-related liabilities, current	15,625		15,625	15,625
Patricia Madaris, CFO [Member]
Related Party Transaction [Line Items]
Employee-related liabilities, current	36,137		36,137	36,137
Spouse of James Briscoe [Member]
Related Party Transaction [Line Items]
Due to related party	16,321		16,321	$ 16,321
CEO [Member]
Related Party Transaction [Line Items]
Due to related party	175,455		175,455
Due to Officers or Stockholders, Current	62,000		62,000
Director [Member] | Promissory Note [Member]
Related Party Transaction [Line Items]
Increase in debt principal amount			5,000
Two Directors [Member] | Promissory Note [Member]
Related Party Transaction [Line Items]
Due to related party	$ 297,707		$ 297,707
Debt instrument, maturity date	Jul. 31, 2021

Schedule of Stock Options Activ

Schedule of Stock Options Activity (Details)	9 Months Ended
	Oct. 31, 2021$ / sharesshares
Share-based Payment Arrangement [Abstract]
Number of options, Outstanding | shares	146,000
Weighted average exercise price per share, Outstanding | $ / shares	$ 3.019
Number of options, Granted | shares
Weighted average exercise price per share, Granted | $ / shares
Number of options, Expired | shares
Weighted average exercise price per share, Expired | $ / shares
Number of options, Exercised | shares
Weighted average exercise price per share, Exercised | $ / shares
Number of options, Outstanding | shares	146,000
Weighted average exercise price per share, Outstanding | $ / shares	$ 3.019
Number of options, Exercisable | shares	146,000
Weighted average exercise price per share, Exercisable | $ / shares	$ 3.019

Stock options (Details Narrativ

Stock options (Details Narrative) - USD ($)	9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Share-based Payment Arrangement [Abstract]
Weighted average remaining life, stock options	6 years 10 months 13 days
Stock options, aggregate intrinsic value	$ 0
Compensation expense	$ 0	$ 0

Schedule of Stock Warrants Outs

Schedule of Stock Warrants Outstanding (Details)	9 Months Ended
	Oct. 31, 2021$ / sharesshares
Weighted average exercise price, Exercisable	$ 1.979
Warrant [Member]
Number of warrants, Outstanding | shares	400,166
Weighted average exercise price, Outstanding	$ 2.155
Number of warrants, Issued | shares	606,084
Weighted average exercise price, Issued	$ 1.846
Number of warrants, Expired | shares
Weighted average exercise price, Expired
Number of warrants, Exercised | shares	(6,000)
Weighted average exercise price, Exercised	$ 0.350
Number of warrants, Outstanding | shares	1,000,250
Weighted average exercise price, Outstanding	$ 1.979
Number of warrants, Exercisable | shares	1,000,250
Weighted average exercise price, Exercisable	$ 1.979

Warrants (Details Narrative)

Warrants (Details Narrative) - USD ($)	Aug. 20, 2021	Aug. 20, 2021	Jul. 17, 2021	Oct. 31, 2021
Share purchase warrants outstanding and exercisable				1,000,250
Warrants weighted average remaining life				3 years 4 months 2 days
Weighted average exercise price of warrant				$ 1.979
Weighted average intrinsic value for warrants outstanding				$ 5,220
Warrant [Member]
Weighted average exercise price of warrant				$ 1.979
Warrant expiration term description			the Company which expired or will expire during the year 2021. These warrants are extended for an additional three years. All other terms of the warrants remain unchanged, including application of the reverse split effective on February 25, 2021.
Investor [Member]
Number of warrants issued				98,552
Warrants terms description				three-year term
Investor [Member] | Minimum [Member]
Warrant exercise price per share				$ 0.805
Investor [Member] | Maximum [Member]
Warrant exercise price per share				$ 1.646
Triton Funds LP Member
Number of warrants issued	507,532	507,532
Triton Funds LP Member | Common Stock [Member]
Purchase of warrants		$ 1,000,000
Triton Funds LP Member | Common Stock [Member]
Purchase right term description	five-year warrants

Schedule of Changes in Fair Val

Schedule of Changes in Fair Value of Derivative Liabilities (Details) - USD ($)	9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Beginning balance
Total (gains) loss	(166,617)	39,631
Settlements	(293,742)	(369,103)
Additions recognized as debt discount	97,434	140,000
Additions due to tainted warrants	686,145	189,472
Ending balance	323,220
Change in unrealized (gain) loss included in earnings relating to derivatives	$ (166,617)	$ 39,631

Derivative Liabilities (Details

Derivative Liabilities (Details Narrative)	3 Months Ended		9 Months Ended
	Oct. 31, 2021USD ($)	Oct. 31, 2020USD ($)	Oct. 31, 2021USD ($)	Oct. 31, 2020USD ($)	Jan. 31, 2021USD ($)
Derivative [Line Items]
Derivative liabilities
Gain (loss) on derivative liability	15,300	$ 0	15,300	$ 0
Gain (loss) on derivative liability	89,627		$ 166,617	(39,631)
Derivative Liability [Member]
Derivative [Line Items]
Conversion note description			Conversion of the notes to stock would be completed monthly after any holding period and would be limited based on: 5% of the last 6 months average trading volume and the ownership limit identified in the contract assuming the underlying number of common shares increases at 1% per month.
Percentage of exercise price for warrant, description			The Holder would exercise the warrant after any holding period prior to maturity at target prices starting at 2 times the exercise price for the Warrants or higher subject to monthly limits of: 5% of the last 6 months average trading volume increasing by 1% per month and the ownership limit identified in the contract assuming the underlying number of common shares increases at 1% per month.
Derivative loss			$ 0
Amortization of debt discount			97,434
Interest expense			78,165
Gain (loss) on derivative liability	19,269		19,269
Reclassification due to conversion of convertible notes			0	189,472
Reclassification due to conversion of convertible notes			293,742	369,103
Gain (loss) on derivative liability			166,617	$ 39,631
Derivative Liability [Member] | Convertible Debt [Member]
Derivative [Line Items]
Derivative liabilities	97,434		97,434
Derivative Liability [Member] | Warrant [Member]
Derivative [Line Items]
Derivative liabilities	$ 686,145		$ 686,145
Minimum [Member] | Measurement Input, Price Volatility [Member]
Derivative [Line Items]
Fair value assumptions, measurement input, percentages	0.754		0.754
Maximum [Member] | Measurement Input, Price Volatility [Member]
Derivative [Line Items]
Fair value assumptions, measurement input, percentages	1.874		1.874

Summary of Convertible Promisso

Summary of Convertible Promissory Notes (Details) - USD ($)	Oct. 31, 2021	Jan. 31, 2021
Debt Instrument [Line Items]
Convertible note payable	$ 165,255	$ 95,611
Less debt discount	(31,006)	(7,642)
Less current portion of convertible notes	(134,249)	(87,969)
Long-term convertible notes payable
8% convertible note payable issued October 2020, due September 2021 [Member]
Debt Instrument [Line Items]
Convertible note payable		95,611
8% convertible note payable issued April 2021, due April 2022 [Member]
Debt Instrument [Line Items]
Convertible note payable	40,596
8% convertible note payable issued May 2021, due May 2022 [Member]
Debt Instrument [Line Items]
Convertible note payable	55,010
8% convertible note payable issued October 2021, due October 2022 [Member]
Debt Instrument [Line Items]
Convertible note payable	$ 69,649

Summary of Convertible Promis_2

Summary of Convertible Promissory Notes (Details) (Parenthetical)	9 Months Ended
	Oct. 31, 2021
8% convertible note payable issued October 2020, due September 2021 [Member]
Debt Instrument [Line Items]
Convertible notes payable, interest rate	8.00%
Debt issuance date	Oct. 31, 2020
Due date	Sep. 30, 2021
8% convertible note payable issued April 2021, due April 2022 [Member]
Debt Instrument [Line Items]
Convertible notes payable, interest rate	8.00%
Debt issuance date	Apr. 30, 2021
Due date	Apr. 30, 2022
8% convertible note payable issued May 2021, due May 2022 [Member]
Debt Instrument [Line Items]
Convertible notes payable, interest rate	8.00%
Debt issuance date	May 31, 2021
Due date	May 31, 2022
8% convertible note payable issued October 2021, due October 2022 [Member]
Debt Instrument [Line Items]
Convertible notes payable, interest rate	8.00%
Debt issuance date	Oct. 31, 2021
Due date	Oct. 31, 2022

Long-term debt and convertibl_3

Long-term debt and convertible promissory notes (Details Narrative)	Oct. 08, 2021USD ($)Integer	May 11, 2021USD ($)Integer	Apr. 27, 2021USD ($)shares	Apr. 26, 2021USD ($)Integershares	Apr. 23, 2021USD ($)shares	Feb. 16, 2021USD ($)	Oct. 28, 2020USD ($)Integer	Jun. 22, 2020USD ($)	Oct. 31, 2021USD ($)shares	May 31, 2021USD ($)shares	Oct. 31, 2021USD ($)	Oct. 31, 2020USD ($)	Oct. 31, 2021USD ($)shares	Oct. 31, 2020USD ($)	Aug. 31, 2021USD ($)
Short-term Debt [Line Items]
Net proceeds from debt													$ 170,000	$ 82,000
Original issue discount amount									$ 15,300		$ 15,300	$ 0	15,300	0
Legal fees											26,253	$ 49,990	52,704	145,462
Debt instrument, face value															$ 13,000
Debt discounts amount													64,823	140,000
Amortization of debt discount													89,370	155,776
Debt including interest													66,796
Debt principal													1,899
SBA's Economic Injury Disaster Loan Program [Member]
Short-term Debt [Line Items]
Debt instrument, maturity date								Jun. 18, 2021
Proceeds from loan								$ 32,300
Loan fee								$ 100
Loan, interest rate								3.75%
Debt term								30 years
Loan installment due amount								$ 158
SBA's Economic Injury Disaster Loan Program [Member] | Extended Maturity [Member]
Short-term Debt [Line Items]
Debt instrument, maturity date								Jun. 18, 2023
PPP Loan [Member]
Short-term Debt [Line Items]
Proceeds from loan						$ 32,497
Loan, interest rate						1.00%
Debt term						5 years
October 2020 Note [Member]
Short-term Debt [Line Items]
Net proceeds from debt							$ 82,000
Debt instrument, interest rate							8.00%
Original issue discount amount							$ 8,500
Legal fees							$ 3,000
Debt instrument, maturity date							Sep. 1, 2021
Debt instrument convertible consecutive trading days | Integer							180
Common stock conversion price per share							75.00%
Debt instrument, convertible, threshold trading days | Integer							10
Debt instrument conversion, amount			$ 15,000		$ 12,000				$ 25,000	$ 69,900			$ 96,900
Debt conversion on convertible shares | shares			18,832		15,049				57,498	98,472			132,353
Principal and interest total amount									$ 0		0		$ 0
April 2021 Note [Member]
Short-term Debt [Line Items]
Net proceeds from debt				$ 60,000
Debt instrument, interest rate				8.00%
Legal fees				$ 3,000
Debt instrument, maturity date				Apr. 23, 2022
Debt instrument convertible consecutive trading days | Integer				180
Common stock conversion price per share				75.00%
Debt instrument, convertible, threshold trading days | Integer				10
Debt instrument conversion, amount				$ 25,000
Debt conversion on convertible shares | shares				57,498
Principal and interest total amount									$ 40,596		$ 40,596		40,596
May 2021 Note [Member]
Short-term Debt [Line Items]
Debt instrument, interest rate		8.00%
Legal fees		$ 3,000
Debt instrument, maturity date		May 11, 2022
Debt instrument convertible consecutive trading days | Integer		180
Common stock conversion price per share		75.00%
Debt instrument, convertible, threshold trading days | Integer		10
Debt instrument, face value		$ 53,000
October 2021 Note Member
Short-term Debt [Line Items]
Debt instrument, interest rate	8.00%
Debt instrument, maturity date	Oct. 8, 2022
Debt instrument convertible consecutive trading days | Integer	180
Common stock conversion price per share	75.00%
Debt instrument, convertible, threshold trading days | Integer	10
Debt instrument, face value	$ 69,300
Promissory Note [Member]
Short-term Debt [Line Items]
Amortization of debt discount													$ 76,028	$ 155,364

Stockholders_ deficit (Details

Stockholders’ deficit (Details Narrative) - USD ($)	Sep. 14, 2021	Aug. 20, 2021	Apr. 27, 2021	Apr. 23, 2021	Apr. 02, 2021	Mar. 26, 2021	Mar. 05, 2021	Nov. 24, 2020	Oct. 31, 2021	May 31, 2021	Apr. 30, 2021	Mar. 31, 2021	Oct. 31, 2021	Oct. 02, 2021	Sep. 30, 2021	Feb. 24, 2021	Jan. 31, 2021	Nov. 23, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' Equity, Reverse Stock Split								On November 24, 2020, the Company filed a Certificate of Change with the Secretary of the State of Nevada to affect a 1-for-500 reverse stock split (the “Reverse Stock Split”)					On November 24, 2020, the Company filed a Certificate of Change with the Secretary of the State of Nevada to affect a 1-for-500 reverse stock split (the “Reverse Stock Split”). The Reverse Stock Split was formally processed by FINRA effective on February 25, 2021, and the Company’s common stock began trading on a split-adjusted basis on February 25, 2021.
Common stock, shares authorized								12,300,000	24,800,000				24,800,000	25,000,000	12,500,000		24,800,000	6,150,000,000
Common stock, shares outstanding									10,785,202				10,785,202				9,902,052
Common stock, shares issued									10,785,202				10,785,202				9,902,052
Common stock, par value									$ 0.00001				$ 0.00001				$ 0.00001
Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of common stock shares issued	490,196
Shares Issued, Price Per Share	$ 0.27
Stock Issued During Period, Value, New Issues	$ 132,374
Estimated market price per share	$ 0.51
Common Class A [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized								200,000	200,000				200,000				0	100,000,000
Common stock, shares outstanding								102,000	102,000				102,000			51,000,000
Number of shares rounded due to reverse stock split								2,408
Common stock, shares issued									102,000				102,000
Voting rights													each share of Class A Stock is entitled to 200 votes
Voting rights percentage of issued and outstanding shares													66.77%
Common stock, par value									$ 0.00001				$ 0.00001				$ 0.00001
October 2020 Note [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares Issued, Price Per Share			$ 0.797	$ 0.797					$ 0.435		$ 1.038		$ 0.435
Proceeds from issuance of common stock and warrants											$ 20,000
Warrants term											3 years
Warrant exercise price per share											$ 1.453
Debt conversion of convertible shares			18,832	15,049					57,498	98,472			132,353
Debt instrument conversion, amount			$ 15,000	$ 12,000					$ 25,000	$ 69,900			$ 96,900
October 2020 Note [Member] | Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares Issued, Price Per Share										$ 0.699
October 2020 Note [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares Issued, Price Per Share										$ 0.743
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares outstanding									10,150,635				10,150,635
Common stock, shares issued									10,150,635				10,150,635
Voting rights													Each share of Common Stock is entitled to 1 vote
Common Stock [Member] | October 2020 Note [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of common stock shares issued											19,268
Warrant [Member] | October 2020 Note [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of common stock shares issued											9,634
CEO [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of common stock shares issued						17,006
Shares Issued, Price Per Share						$ 1.176
Warrants purchase						8,503
Proceeds from issuance of common stock and warrants						$ 20,000
Warrants term						3 years
Warrant exercise price per share						$ 1.646
CEO [Member] | Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of common stock shares issued												49,412
Shares Issued, Price Per Share												$ 1.113
Warrants purchase												24,706
Proceeds from issuance of common stock and warrants												$ 55,000
Warrants term												3 years
Warrant exercise price per share												$ 1.558
Director [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares Issued, Price Per Share									$ 0.575				$ 0.575
Proceeds from issuance of common stock and warrants									$ 35,000
Director [Member] | Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of common stock shares issued									60,887
Director [Member] | Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of common stock shares issued									30,444
Warrants term									3 years				3 years
Warrant exercise price per share									$ 0.805				$ 0.805
Directors One [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares Issued, Price Per Share									$ 0.577				$ 0.577
Proceeds from issuance of common stock and warrants									$ 15,000
Directors One [Member] | Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of common stock shares issued									12,993
Directors One [Member] | Common Stock One [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of common stock shares issued									25,986
Directors One [Member] | Warrants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants term									3 years				3 years
Warrant exercise price per share									$ 0.808				$ 0.808
Accredited Investor [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of common stock shares issued					9,818		6,000
Proceeds from issuance of warrants							$ 2,100
Shares Issued, Price Per Share					$ 1.019		$ 0.35
Warrants purchase					4,909
Proceeds from issuance of common stock and warrants					$ 10,000
Warrants term					3 years
Warrant exercise price per share					$ 1.426
Triton Funds LP Member
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants purchase		507,532
Triton Funds LP Member | Common Stock [Member] | Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock available for purchase to related party		$ 1,000,000
Purchase condition		It may require Triton to purchase not less than $25,000 or more than $250,000 per month of its common stock at a purchase price equal to 75% of the lowest daily volume-weighted average price of the Company’s common stock during the 5 business days immediately prior to the date of closing of each separate purchase installment
Purchase right term		5 years
Additional shares available for purchase to related party		$ 1,000,000
Market capitalization amount of outstanding shares		20,000,000
Triton Funds LP Member | Common Stock [Member] | Minimum [Member] | Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Purchase limit per month		25,000
Triton Funds LP Member | Common Stock [Member] | Maximum [Member] | Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Purchase limit per month		250,000
Triton Funds LP Member | Warrant [Member] | Warrant Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock available for purchase to related party		$ 1,000,000

Commitments and contingencies (

Commitments and contingencies (Details Narrative)	Aug. 22, 2019USD ($)
Former Chief Executive Officer [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Loss Contingency, Damages Sought, Value	$ 50,000

Subsequent events (Details Narr

Subsequent events (Details Narrative)	Nov. 15, 2021USD ($)Integer	Apr. 26, 2021USD ($)Integershares	Dec. 31, 2021USD ($)$ / sharesshares	Nov. 30, 2021USD ($)$ / sharesshares	Aug. 31, 2021USD ($)
Subsequent Event [Line Items]
Debt instrument, face value					$ 13,000
Convertiable Promissory Note [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Debt instrument, face value	$ 60,500
Debt instrument, interest rate	8.00%
Discount percentage	10.00%
Debt instrument, maturity date	Nov. 15, 2022
Debt instrument convertible consecutive trading days | Integer	180
Common stock conversion price per share	75.00%
Debt instrument, convertible, threshold trading days | Integer	10
April 2021 Note [Member]
Subsequent Event [Line Items]
Debt instrument, interest rate		8.00%
Debt instrument, maturity date		Apr. 23, 2022
Debt instrument convertible consecutive trading days | Integer		180
Common stock conversion price per share		75.00%
Debt instrument, convertible, threshold trading days | Integer		10
Debt instrument conversion, amount		$ 25,000
Debt conversion on convertible shares | shares		57,498
April 2021 Note [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Debt instrument conversion, amount				$ 40,520
Debt conversion on convertible shares | shares				103,692
Shares Issued, Price Per Share | $ / shares				$ 0.39
May Two Thousandand Twenty One Note [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Debt instrument conversion, amount			$ 40,000	$ 40,000
Debt conversion on convertible shares | shares			166,988	166,988
Shares Issued, Price Per Share | $ / shares			$ 0.24	$ 0.24